Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on August 10, 2005
J Am Soc Nephrol 16: 2531-2532, 2005
© 2005 American Society of Nephrology
doi: 10.1681/ASN.2005070740

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005070740v1
16/9/2531    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lackland, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lackland, D. T.

Editorials

Mechanisms and Fetal Origins of Kidney Disease

Daniel T. Lackland

Medical University of South Carolina, Charleston, South Carolina

Address correspondence to: Dr. Daniel Lackland, Medical University of South Carolina, 135 Cannon Street, Charleston, SC 29425. Phone: 843-876-1141; Fax: 843-876-1143; lackland{at}musc.edu

The kidney disease epidemic remains a major public health burden with exponentially increasing trends such as will overtake the health care budget in the coming decades if not averted (13). Kidney failure and ESRD also demonstrate racial and geographic disparities with excess risks for segments of the population (13). As kidney function declines with the aging process, the challenge is to slow the disease progression process. Thus, it is critical to identify the factors associated with the disease risks and disease progression. Clearly, hypertension and diabetes are major factors involved in the progression of kidney disease. However, the increasing trends in disease incidence and early onset of kidney failure indicate other parameters are also involved in the disease progression.

Professor David Barker introduced the "Fetal Origins of Adult Disease Hypothesis" over a decade ago, identifying associations of fetal and early life events with adult chronic diseases (4,5). Numerous epidemiologic studies have confirmed the associations suggesting fetal programming and mechanisms associated with disease progression. Identification of these mechanisms is essential in the development of interventions to reduce the disease risks (6). With the increasing burden of disease and the development of the renal system in utero, the focus on the kidney in assessment for a fetal etiology is logical (7). Indeed, ESRD was inversely associated with birth weight for white and black men and women (8). The association was significant for all causes of ESRD (i.e., hypertension, diabetes, other, and unknown), with greatest risks in subjects with lower birth weights (9). The increased risks remained evident after adjustments for family history of ESRD (10).

Various mechanisms have been proposed to explain the fetal origins of kidney disease. Both hypertension and diabetes have been shown to be associated with birth weight, (11,12) increasing the risks of kidney disease. Uncontrolled high BP and diabetes increase the progression of renal failure and ESRD. Renal development in utero resulting in the number of nephrons has been proposed as a mechanism for the increased adult disease risk (13,14). This reduced fetal growth of the kidney is associated with defects in the development of the kidney increasing the vulnerability to various pathologic processes (15,16). Brenner and Mackenzie (15) have suggested that retarded fetal growth results in a reduced number of nephrons, which is further associated with increased hydrostatic pressure in the glomerular capillaries and glomerular hyperfiltration (15). Increased pressure and hyperfiltration increase the development of glomerular sclerosis. Fetal development and early life events are also associated with the renin-angiotensin system, and the subsequent development of elevated BP and disease process (17). The development of blood vessels and arterial walls has also been associated with fetal development, with stiffer vessel associated with low birth weight (18). Most likely, there are multiple mechanisms associated with the fetal origins of kidney disease. Among individuals with hypertension, different antihypertensive treatment classes were associated with birth weight, supporting the concept of different mechanisms involved with disease risks (19).

In this issue of the Journal of the American Society of Nephrology, Keijzer-Veen and colleagues (20) have identified a significant positive association of birth weight and GFR. The investigators also detected a negative association of birth weight and serum creatinine (20), suggesting that individuals born premature and/or small at birth are at greater risk to develop progressive renal failure. This work makes a significant contribution to understanding the mechanisms associated with the progression of ESRD and birth weight by identifying risk prior to the end-organ disease. Nonetheless, the study has some limitations that must be noted. There is a potential selection bias, and it is difficult to predict the future effects of birth weight on renal function as the subjects age. However, the authors have identified a factor that fits a scheme identified by numerous other studies. It is essential to accurately identify such mechanisms to develop interventions for reducing the disease risks early in life (21). The study of the fetal origins has several challenges, including the complicated study design, unclear genetic-environment relationships, and the fact that some disease processes in the population do not have a fetal origin. However, with the magnitude of the ESRD epidemic and increasing disease burden of kidney disease with an unclear etiology, the continued study of fetal origins is reasonable and logical, and the findings of investigators such as Keijzer-Veen et al. should be considered in the development of future investigations and studies.

Footnotes

Published online ahead of print. Publication date available at www.jasn.org.

References

  1. Lackland DT, Moore MA: Hypertension-related mortality and morbidity in the Southeast. South Med J 90 : 191 –198, 1997[Medline]
  2. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Flag MJ: The excess incidence of diabetic end-stage renal disease among blacks: A population-based study of potential explanatory factors. JAMA 268 : 3079 –3084, 1992[Abstract/Free Full Text]
  3. McClellan W: Hypertensive end-stage renal disease in blacks: The role of end-stage renal disease surveillance. Am J Kidney Dis 21 : 25 –30, 1993[Medline]
  4. Fetal and Infant Origins of Adult Disease, edited by Barker DJP, London, BMJ Publishing, 1992
  5. Barker DJP, Winter PD, Osmond C, Margetts B, Simmonds SJ: Weight in infancy and death from ischemic heart disease. Lancet 2 : 577 –580, 1989[Medline]
  6. Lucas A, Fewtrell MS, Cole TJ: Fetal origins of adult disease—The hypothesis revisited. Lancet 319 : 245 –249, 2002[CrossRef]
  7. Gillman M: Epidemiological challenges in studying the fetal origins of adult chronic disease. Int J Epidemiol 31 : 294 –299, 2002[Free Full Text]
  8. Lackland DT, Egan BM, Bendall HE, Osmond C: Low birth weight and the emerging burden of renal disease in the United States. In: Fetal Origin of Cardiovascular and Lung Disease, edited by Barker DJP, New York, Marcel Dekker, 2000 , pp 61 –71
  9. Lackland DT, Bendall HE, Osmond C, Egan BM, Barker DJP: Low birth weight contributes to the high rates of early onset chronic renal failure in the Southeast United States. Arch Intern Med 160 : 1472 –1476, 2000[Abstract/Free Full Text]
  10. Fan ZJ, Lackland DT, Kenderes B, Krisha J, Freedman BI: The impact of birth weight on familial aggregation of end-stage renal disease. Am J Nephrol 23 : 117 –120, 2003[CrossRef][Medline]
  11. Lackland DT, Egan BM, Ferguson PL: Low birth weight as a risk factor for hypertension. J Clin Hypertens (Greenwich) 5 : 133 –136, 2003[Medline]
  12. Barker DJP: The fetal origins of type 2 diabetes mellitus. Ann Intern Med 130 : 322 –324, 1999[Free Full Text]
  13. Brenner BM, Chertow GM: Congenital oligonephropathy: An inborn cause of adult hypertension and progressive renal injury. Curr Opin Nephrol Hypertens 2 : 691 –695, 1993[Medline]
  14. Mackenzie HS, Brenner BM: Fewer nephrons at birth: A missing link in the etiology of essential hypertension? Am J Kidney Dis 26 : 91 –98, 1992
  15. Brenner BM, Mackenzie HS: Nephron mass as a risk factor for progression of renal disease. Kidney Int Suppl 63 : S124 –S127, 1997[Medline]
  16. Hinchliffe SA, Lynch MR, Sargent PH, Howard CV, Van Velzen D. The effect of intrauterine growth retardation on the development of renal nephrons. Br J Obstet Gynaecol 99 : 296 –301, 1992[Medline]
  17. Woods LL: Fetal origins of adult hypertension: A renal mechanism? Curr Opin Nephrol Hypertens 9 : 419 –425, 2000[CrossRef][Medline]
  18. Broyd C, Harrison E, Raja M, Millasseau SC, Poston L, Chowienczyk: Association of pulse waveform characteristics with birth weight in young adults. J Hypertens 23 : 1391 –1396, 2005[Medline]
  19. Lackland DT, Egan BM, Syddall HE, Barker DJP: Associations between birth weight and antihypertensive medication in black and white Medicaid recipients. Hypertension 39 : 179 –183, 2002[Abstract/Free Full Text]
  20. Keijzer-Veen MG, Schrevel M, Finken MJJ, Dekker FW, Nauta J, Hille ETM, Frolich M, van der Heijden BJ; on behalf of the Dutch POPS-19 Collaborative Study Group: Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. J Am Soc Nephrol 16 : 2762 –2768, 2005[Abstract/Free Full Text]
  21. Byrne CD, Phillips DI: Fetal origins of adult disease: Epidemiology and mechanisms. J Clin Path 53 : 822 –828, 2000[Abstract/Free Full Text]




This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2005070740v1
16/9/2531    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lackland, D. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lackland, D. T.


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP